Indivior (OTCMKTS:INVVY) Shares Down 1.8% – Here’s Why

Indivior PLC (OTCMKTS:INVVY – Get Free Report) shares traded down 1.8% during trading on Friday. The stock traded as low as $21.64 and last traded at $21.8455. 8,100 shares were traded during mid-day trading, an increase of 112% from the average session volume of 3,825 shares. The stock had previously closed at $22.25.

Indivior Stock Performance

The firm has a market capitalization of $3.01 billion, a P/E ratio of 20.81 and a beta of 0.35. The stock has a 50-day moving average of $21.85 and a 200 day moving average of $21.85.

About Indivior

(Get Free Report)

Indivior is a pharmaceutical company focused on treatments for substance use disorders, particularly opioid use disorder, as well as select mental health conditions. Its products include SUBLOCADE, an extended-release buprenorphine injection, and SUBOXONE, a buprenorphine and naloxone treatment for opioid use disorder. The company also markets PERSERIS, an extended-release risperidone injection for schizophrenia. Indivior was established as an independent company in 2014 through a demerger from Reckitt Benckiser.

Further Reading

Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.